Member Innovation Spotlight: Science Corporation’s PRIMA Retinal Implant Restores Vision
Topic : Innovation Type : Briefing
ABHI member Science Corporation has reached a remarkable milestone with the publication of a peer-reviewed paper in The New England Journal of Medicine, showcasing the results of a landmark clinical trial of its PRIMA brain-computer interface (BCI) retinal implant.
The study demonstrated that PRIMA successfully restored functional central vision in patients suffering from geographic atrophy caused by age-related macular degeneration (AMD), a leading cause of blindness worldwide.
This breakthrough highlights the potential of advanced HealthTech innovations to restore independence and improve quality of life for millions living with sight loss.
Read the full announcement on Science Corporation’s website here.